UniProt ID | VPS4A_HUMAN | |
---|---|---|
UniProt AC | Q9UN37 | |
Protein Name | Vacuolar protein sorting-associated protein 4A | |
Gene Name | VPS4A {ECO:0000312|EMBL:AAG01470.1} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 437 | |
Subcellular Localization |
Prevacuolar compartment membrane Peripheral membrane protein. Late endosome membrane Peripheral membrane protein . Midbody. Membrane-associated in the prevacuolar endosomal compartment. Localizes to the midbody of dividing cells, interaction with |
|
Protein Description | Involved in late steps of the endosomal multivesicular bodies (MVB) pathway. Recognizes membrane-associated ESCRT-III assemblies and catalyzes their disassembly, possibly in combination with membrane fission. Redistributes the ESCRT-III components to the cytoplasm for further rounds of MVB sorting. MVBs contain intraluminal vesicles (ILVs) that are generated by invagination and scission from the limiting membrane of the endosome and mostly are delivered to lysosomes enabling degradation of membrane proteins, such as stimulated growth factor receptors, lysosomal enzymes and lipids. In conjunction with the ESCRT machinery also appears to function in topologically equivalent membrane fission events, such as the terminal stages of cytokinesis and enveloped virus budding (HIV-1 and other lentiviruses). Involved in cytokinesis: retained at the midbody by ZFYVE19/ANCHR and CHMP4C until abscission checkpoint signaling is terminated at late cytokinesis. It is then released following dephosphorylation of CHMP4C, leading to abscission. [PubMed: 24814515 VPS4A/B are required for the exosomal release of SDCBP, CD63 and syndecan] | |
Protein Sequence | MTTSTLQKAIDLVTKATEEDKAKNYEEALRLYQHAVEYFLHAIKYEAHSDKAKESIRAKCVQYLDRAEKLKDYLRSKEKHGKKPVKENQSEGKGSDSDSEGDNPEKKKLQEQLMGAVVMEKPNIRWNDVAGLEGAKEALKEAVILPIKFPHLFTGKRTPWRGILLFGPPGTGKSYLAKAVATEANNSTFFSVSSSDLMSKWLGESEKLVKNLFELARQHKPSIIFIDEVDSLCGSRNENESEAARRIKTEFLVQMQGVGNNNDGTLVLGATNIPWVLDSAIRRRFEKRIYIPLPEEAARAQMFRLHLGSTPHNLTDANIHELARKTEGYSGADISIIVRDSLMQPVRKVQSATHFKKVCGPSRTNPSMMIDDLLTPCSPGDPGAMEMTWMDVPGDKLLEPVVCMSDMLRSLATTRPTVNADDLLKVKKFSEDFGQES | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Phosphorylation | ------MTTSTLQKA ------CCHHHHHHH | 29.47 | 24043423 | |
3 | Phosphorylation | -----MTTSTLQKAI -----CCHHHHHHHH | 20.58 | 24043423 | |
4 | Phosphorylation | ----MTTSTLQKAID ----CCHHHHHHHHH | 20.25 | 24043423 | |
5 | Phosphorylation | ---MTTSTLQKAIDL ---CCHHHHHHHHHH | 30.99 | 24043423 | |
8 | Acetylation | MTTSTLQKAIDLVTK CCHHHHHHHHHHHHH | 50.88 | 19608861 | |
15 | Ubiquitination | KAIDLVTKATEEDKA HHHHHHHHCCHHHHC | 45.92 | - | |
23 | Methylation | ATEEDKAKNYEEALR CCHHHHCCCHHHHHH | 66.84 | 115978737 | |
25 | Phosphorylation | EEDKAKNYEEALRLY HHHHCCCHHHHHHHH | 17.91 | 29496907 | |
59 | Malonylation | AKESIRAKCVQYLDR HHHHHHHHHHHHHHH | 25.70 | 26320211 | |
59 | Acetylation | AKESIRAKCVQYLDR HHHHHHHHHHHHHHH | 25.70 | 20167786 | |
69 | Acetylation | QYLDRAEKLKDYLRS HHHHHHHHHHHHHHH | 60.91 | 20167786 | |
71 | Acetylation | LDRAEKLKDYLRSKE HHHHHHHHHHHHHHH | 56.23 | 20167786 | |
73 | Phosphorylation | RAEKLKDYLRSKEKH HHHHHHHHHHHHHHH | 11.48 | 21253578 | |
90 | Phosphorylation | KPVKENQSEGKGSDS CCCCCCCCCCCCCCC | 60.96 | 23927012 | |
95 | Phosphorylation | NQSEGKGSDSDSEGD CCCCCCCCCCCCCCC | 37.11 | 29255136 | |
97 | Phosphorylation | SEGKGSDSDSEGDNP CCCCCCCCCCCCCCH | 44.74 | 29255136 | |
99 | Phosphorylation | GKGSDSDSEGDNPEK CCCCCCCCCCCCHHH | 47.64 | 23401153 | |
121 | Ubiquitination | MGAVVMEKPNIRWND HHHHHCCCCCCCHHH | 25.85 | - | |
136 | Ubiquitination | VAGLEGAKEALKEAV CCCCHHHHHHHHHCC | 55.14 | - | |
140 | Ubiquitination | EGAKEALKEAVILPI HHHHHHHHHCCEEEC | 51.15 | 21890473 | |
148 | Ubiquitination | EAVILPIKFPHLFTG HCCEEECCCCCCCCC | 51.40 | 21890473 | |
156 | Acetylation | FPHLFTGKRTPWRGI CCCCCCCCCCCCEEE | 50.47 | 12435693 | |
156 | Ubiquitination | FPHLFTGKRTPWRGI CCCCCCCCCCCCEEE | 50.47 | 21890473 | |
171 | Phosphorylation | LLFGPPGTGKSYLAK EEECCCCCCHHHHHH | 47.40 | - | |
173 | Ubiquitination | FGPPGTGKSYLAKAV ECCCCCCHHHHHHHH | 35.45 | 21890473 | |
174 | Phosphorylation | GPPGTGKSYLAKAVA CCCCCCHHHHHHHHH | 27.07 | 28857561 | |
175 | Phosphorylation | PPGTGKSYLAKAVAT CCCCCHHHHHHHHHH | 17.73 | - | |
178 | Ubiquitination | TGKSYLAKAVATEAN CCHHHHHHHHHHHCC | 40.58 | - | |
207 | Ubiquitination | KWLGESEKLVKNLFE HHHCCHHHHHHHHHH | 68.79 | - | |
210 | Ubiquitination | GESEKLVKNLFELAR CCHHHHHHHHHHHHH | 59.37 | 21890473 | |
220 | Ubiquitination | FELARQHKPSIIFID HHHHHHHCCCEEEEE | 31.93 | - | |
231 | Phosphorylation | IFIDEVDSLCGSRNE EEEECHHHHCCCCCC | 30.63 | 25627689 | |
235 | Phosphorylation | EVDSLCGSRNENESE CHHHHCCCCCCCHHH | 30.82 | 25627689 | |
290 | Phosphorylation | RRFEKRIYIPLPEEA HHHHHCCCCCCCHHH | 10.66 | 27642862 | |
309 | Phosphorylation | MFRLHLGSTPHNLTD HHHHHCCCCCCCCCH | 45.16 | 20873877 | |
310 | Phosphorylation | FRLHLGSTPHNLTDA HHHHCCCCCCCCCHH | 27.11 | 20873877 | |
315 | Phosphorylation | GSTPHNLTDANIHEL CCCCCCCCHHCHHHH | 38.08 | 20873877 | |
329 | Phosphorylation | LARKTEGYSGADISI HHHHCCCCCCCCEEE | 9.56 | 22817900 | |
335 | Phosphorylation | GYSGADISIIVRDSL CCCCCCEEEEEECCC | 13.55 | 24850871 | |
348 | Ubiquitination | SLMQPVRKVQSATHF CCCCCHHHHHHCCCH | 44.88 | - | |
351 | Phosphorylation | QPVRKVQSATHFKKV CCHHHHHHCCCHHHH | 37.82 | 23312004 | |
353 | Phosphorylation | VRKVQSATHFKKVCG HHHHHHCCCHHHHHC | 32.85 | 23312004 | |
356 | Ubiquitination | VQSATHFKKVCGPSR HHHCCCHHHHHCCCC | 36.37 | - | |
378 | Phosphorylation | DDLLTPCSPGDPGAM HHCCCCCCCCCCCCC | 32.87 | 28348404 | |
410 | Phosphorylation | CMSDMLRSLATTRPT CHHHHHHHHHHCCCC | 20.56 | 28857561 | |
414 | Phosphorylation | MLRSLATTRPTVNAD HHHHHHHCCCCCCHH | 29.10 | 28857561 | |
425 | Ubiquitination | VNADDLLKVKKFSED CCHHHHHHHHHHHHH | 60.34 | - | |
428 | Ubiquitination | DDLLKVKKFSEDFGQ HHHHHHHHHHHHHCC | 58.05 | - | |
437 | Phosphorylation | SEDFGQES------- HHHHCCCC------- | 37.32 | 25159151 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of VPS4A_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of VPS4A_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of VPS4A_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
NPC1_HUMAN | NPC1 | physical | 16757520 | |
CHMP5_HUMAN | CHMP5 | physical | 21543490 | |
CHMP3_HUMAN | CHMP3 | physical | 21543490 | |
GAG_HV1H2 | gag | physical | 20164219 | |
VTA1_HUMAN | VTA1 | physical | 20164219 | |
CHM1B_HUMAN | CHMP1B | physical | 14505570 | |
CHM2A_HUMAN | CHMP2A | physical | 14505570 | |
CHM4A_HUMAN | CHMP4A | physical | 14505569 | |
CHM1A_HUMAN | CHMP1A | physical | 16730941 | |
CHM1B_HUMAN | CHMP1B | physical | 16730941 | |
CHM4A_HUMAN | CHMP4A | physical | 16730941 | |
CHM4B_HUMAN | CHMP4B | physical | 16730941 | |
VPS4A_HUMAN | VPS4A | physical | 16730941 | |
AT1A3_HUMAN | ATP1A3 | physical | 26186194 | |
VPS4B_HUMAN | VPS4B | physical | 26186194 | |
RHEB_HUMAN | RHEB | physical | 26186194 | |
ANCHR_HUMAN | ZFYVE19 | physical | 26186194 | |
VTA1_HUMAN | VTA1 | physical | 26186194 | |
ARL8B_HUMAN | ARL8B | physical | 26186194 | |
ANCHR_HUMAN | ZFYVE19 | physical | 28514442 | |
VPS4B_HUMAN | VPS4B | physical | 28514442 | |
VTA1_HUMAN | VTA1 | physical | 28514442 | |
ARL8B_HUMAN | ARL8B | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-8, AND MASS SPECTROMETRY. |